Blood consult: Monosomal karyotype acute myeloid leukemia

Blood

Volumn 119, Issue 24, 2012, Pages 5659-5660

  Garcia, Jacqueline S ^a   Medeiros, Bruno C ^a   Appelbaum, Frederick R ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIFUNGAL AGENT; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD64 ANTIGEN; CYTARABINE; GLYCOPROTEIN P 15095; HEMOGLOBIN; HLA DR ANTIGEN; IDARUBICIN; LACTATE DEHYDROGENASE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; PREDNISONE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOID HYPERTROPHY; ADULT; ARTICLE; AUDITORY TUBE DYSFUNCTION; BLAST CELL; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CORTICOSTEROID THERAPY; FAMILY HISTORY; FEBRILE NEUTROPENIA; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HLA TYPING; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; KARYOTYPE 46,XX; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LUNG MYCOSIS; LUNG NODULE; MONOSOMAL KARYOTYPE ACUTE MYELOID LEUKEMIA; NIGHT SWEAT; OTITIS MEDIA; PERICARDITIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT DURATION;

EID: 84862501694     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-405225     Document Type: Article

References (13)

1. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
2. Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol. 2008;26(29):4791-4797.
3. Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood. 2010;116(13):2224-2228.
4. Perrot A, Luquet I, Pigneux A, et al. Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood. 2011;118(3):679-685.
5. Rucker FG, Schlenk RF, Bullinger L, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012;119(9):2114-2121.
6. Kayser S, Zucknick M, Dohner K, et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood. 2012;119(2):551-558.
7. Xie B, Othus M, Medeiros BC, Fang M, Appelbaum FR, Estey EH. Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype. Haematologica. 2011;96(4):631-632.
8. Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med. 2009;361(13):1249-1259.
9. Lowenberg B, Ossenkoppele GJ, van Putten W, et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med. 2009;361(13):1235-1248.
10. Ahn HK, Jang JH, Kim K, et al. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity. Am J Hematol. 2012;87(1):37-41.
11. Lowenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027-1036.
12. Medeiros BC, Othus M, Appelbaum FR. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(22):2167-2168; author reply 2168-2169.
13. Fang M, Storer B, Estey E, et al. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood. 2011;118(6):1490-1494.